Have You Taken Zantac Regularly and Been Diagnosed with Cancer?
Step 1
Let Us File Your Lawsuit!
Drug companies have an obligation to inform the public about any harmful side effects of drugs they create and market. When a drugmaker fails to provide adequate warnings about the risks related to the use of a particular drug, it could be held liable in lawsuits for injuries and damages that may result. Let us help you get a qualified opinion on your potential Ranitidine lawsuit. We will charge no fee unless your case is successful.
Zantac’s Active Ingredient – Ranitidine – is Found to Increase the Risk of Cancer
Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. Health Canada is closely assessing the issue in collaboration with other regulators internationally, including the U.S. Food and Drug Administration and the European Medicines Agency. The Department will take action as needed, and will keep Canadians informed.
Zantac is used to treat the following conditions:
Acid Indigestion
Heart Burn
Erosive Esophagitis
Gastroesophageal Reflux Disease (GERD)
Zollinger-Ellison Syndrome
Zantac has been Found to Contain High Levels of the Cancer Causing Chemical, NDMA
The Zantac lawsuits claim that Zantac can be contaminated with the cancer-causing substance N-nitrosodimethylamine (NDMA).
What is NDMA?
NDMA is used in aviation and rocket fuel and industrial lubricants. It is also a by-product of several industrial processes, including gasoline refining and the treatment of wastewater containing nitrogen. Other applications for NDMA include inducing carcinogenesis in laboratory rats for cancer research.
The exact cause of the NDMA contamination in Zantac and other generic heartburn medications is still under investigation. However, during the period in which Boerhinger Ingelheim and Sanofi manufactured and marketed Zantac, scientific research demonstrated a clear link between ranitidine, the active ingredient in Zantac, and NDMA.
Despite the availability of this information, the drugmakers chose not to disclose this risk to the government or to consumers. For years, due to a very high perception of ranitidine’s safety, Zantac and its generic equivalents were heavily prescribed to adults and infants and sold over-the-counter.
Health Canada continues investigation as more heartburn medications recalled
Health Canada assessing NDMA in ranitidine
Health Canada has recalled another group of ranitidine medications
NDMA is classified as a probable human carcinogen, which means long-term exposure to levels above what is considered safe could increase the risk of cancer. We are all exposed to low levels of NDMA in some foods (such as meats, dairy products and vegetables) and in drinking water. NDMA is not expected to cause harm when ingested at very low levels.
Ranitidine is available in Canada over-the-counter (for example, under the brand name Zantac and as generics) and by prescription (as generics). Over-the-counter ranitidine is approved to prevent and relieve heartburn associated with acid ingestion and sour stomach. Prescription ranitidine drugs are used to reduce stomach acid for the treatment and prevention of various conditions, such as heartburn, ulcers of the stomach and intestines, and gastroesophageal reflux disease (commonly known as GERD).
The choice of a lawyer is an important decision and should not be based solely upon advertisements.
By clicking above, I agree to receive telephone calls and text messages at the telephone number provided above/below (including any mobile number provided) by our law firm. I understand that consent is not a condition to receive the services and that I may revoke my consent at any time. I also have read and agree to your Privacy Policy.